Asai M, Oki T, Ohkushi H, Ishimoto T, Tominaga T, Taoka M, Fukuda N, Niki T, Mori H
J Cardiogr. 1985 Jun;15(2):399-413.
The effect of sublingual nifedipine on left ventricular (LV) function was assessed by analyzing LV inflow velocity patterns using pulsed Doppler echocardiography (PDE) and radioisotope (RI) angiography in 23 patients with hypertrophic cardiomyopathy (HCM), 13 with hypertensive heart disease (HHD) and 24 with ischemic heart disease (IHD). The results were as follows: LV inflow velocity pattern and M-mode echocardiography after the administration of nifedipine (Study-I). The deceleration time (DT) of the diastolic rapid filling wave was shortened after nifedipine in HCM and HHD, but not in IHD. The acceleration time (AT) of the diastolic rapid filling wave and the A/D ratio (amplitude of an atrial contraction wave/amplitude of a diastolic rapid filling wave) were not significantly changed in all groups. Peak negative Vcf was significantly improved after nifedipine in HCM, but unchanged in the other groups. Fractional shortening and peak Vcf did not change in all groups. LV inflow velocity pattern and RI angiography after nifedipine (Study-II). The mean LV rapid filling rate (V1) based on the LV volume curve by multi-gated blood pool scans increased during nifedipine in HCM and HHD, but other diastolic indices, such as the peak filling rate and 1/3 filling fraction, were unchanged. The DT-V1 relationship during nifedipine shifted toward the right and downward in HCM and HHD. In IHD, however, this relationship shifted toward the left and downward in cases with reduced LV function (V1 less than 1.0 EDC/sec), but toward the right and downward in patients whose LV function was maintained (V1 greater than or equal to 1.0 EDC/sec). Nifedipine therapy was associated with an improved LV filling in nearly all cases of HCM and HHD, and in some cases of IHD. PDE and RI angiography are useful for evaluating LV diastolic function during sublingual nifedipine in various heart diseases.
采用脉冲多普勒超声心动图(PDE)和放射性核素(RI)血管造影分析左心室流入速度模式,评估23例肥厚型心肌病(HCM)、13例高血压性心脏病(HHD)和24例缺血性心脏病(IHD)患者舌下含服硝苯地平对左心室(LV)功能的影响。结果如下:硝苯地平给药后左心室流入速度模式和M型超声心动图(研究一)。硝苯地平给药后,HCM和HHD患者舒张期快速充盈波的减速时间(DT)缩短,但IHD患者未缩短。舒张期快速充盈波的加速时间(AT)和A/D比值(心房收缩波幅度/舒张期快速充盈波幅度)在所有组中均无显著变化。HCM患者硝苯地平给药后负向峰值Vcf显著改善,但其他组无变化。所有组的缩短分数和峰值Vcf均无变化。硝苯地平给药后左心室流入速度模式和RI血管造影(研究二)。多门控血池扫描基于左心室容积曲线的平均左心室快速充盈率(V1)在HCM和HHD患者服用硝苯地平时增加,但其他舒张期指标,如峰值充盈率和1/3充盈分数无变化。HCM和HHD患者服用硝苯地平时DT-V1关系向右下方移动。然而,在IHD患者中,左心室功能降低(V1小于1.0 EDC/秒)的病例中,这种关系向左下方移动,但左心室功能维持(V1大于或等于1.0 EDC/秒)的患者中,这种关系向右下方移动。几乎所有HCM和HHD病例以及一些IHD病例中,硝苯地平治疗均与左心室充盈改善相关。PDE和RI血管造影有助于评估各种心脏病患者舌下含服硝苯地平时的左心室舒张功能。